Circulating ketone bodies and mortality in heart failure: a community cohort study

Rebecca O Oyetoro1, Katherine M Conners1, Jungnam Joo2

  • 1Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.

PubMed

Insights

Ketone bodies (KB) are linked to increased mortality risk in heart failure (HF) patients, especially those with preserved ejection fraction. This study clarifies KB distribution and its association with HF progression and survival outcomes.

Area of Science:

  • Cardiology
  • Metabolic Research
  • Clinical Investigation

Background:

  • The prognostic significance of ketone bodies (KB) in heart failure (HF) remains unclear.
  • Understanding KB levels can offer new insights into HF pathophysiology and patient outcomes.

Purpose of the Study:

  • To determine KB distribution in a heart failure cohort.
  • To identify clinical factors associated with KB levels.
  • To investigate the relationship between plasma KB and all-cause mortality in HF patients.

Main Methods:

  • Plasma KB levels were quantified using nuclear magnetic resonance spectroscopy.
  • Multivariable linear regression analyzed associations between clinical factors and KB.
  • Proportional hazard regression assessed the link between KB and mortality, adjusting for covariates.

Main Results:

  • Higher KB levels correlated with advanced HF (NYHA class III-IV) and elevated NT-proBNP.
  • Increased KB levels were independently associated with a higher risk of all-cause mortality (HR 1.23).
  • This association was more pronounced in patients with preserved ejection fraction.

Conclusions:

  • Most heart failure patients had KB levels comparable to healthy individuals, but elevated levels indicated advanced disease.
  • Higher ketone body levels signify an increased mortality risk in heart failure, particularly in the preserved ejection fraction subgroup.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
92
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
158
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.6K
Metabolic States of the Body: Fasting and Starvation01:24

Metabolic States of the Body: Fasting and Starvation

During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
1.4K